Summit Therapeutics Share Discussion Threads

[1gw] 10/2/2020 23:26

Yes, looks pleasingly simple and cost-free wirh HL.

[waterloo01] 10/2/2020 20:14

Well done then and thanks.

[chrisatrdg] 10/2/2020 20:10

Agree waterloo01 on both points.

I have been working with Summit on the issue for the last two months who also spoke to II to explain the situation re Mellon Bank etc.Process came out within a week of such discussions & others followed.

[waterloo01] 10/2/2020 20:03

Chrisatdrg, Barclays are just awful. Have been so for sometime. I only have one account left with them. They did however say they would have transferred them to another broker, but as they were in an ISA I sold.

I've instructed HL to convert today, I assume without any charges, which is a result.

[chrisatrdg] 10/2/2020 19:24

Just listened to US presentation which ended with no questions which was disappointing and it was not Glyn Edwards making the presentation.

Edit: There are some new slides.

[chrisatrdg] 10/2/2020 18:51

Hi waterloo01 - I was with Barclays & they were not linked to the NASDAQ so I had to convert to certs & registered them with Interactive Investors (II) who are doing the conversion as you described Barclays gave me no choice in December.It was transfer out or they would be sold.

My Barclay shares only got into my II account this morning after instructing Barclays last December.I have been to hell & back between the registra & Barclays.

Finally got £100 compensation & 2 bottles of wine from Barclays & one big headache.Regards.

[waterloo01] 10/2/2020 17:06

Just out. So easy to convert. No charges or stamp duty if done before 21st Feb. Also confirms can't be held in ISA (with HL anyhow) . Chris, not sure why you bothered with paper?

There is no conversion fee up until the delisting of the Shares from AIM. After close of business on 21 February 2020, conversion into ADRs may incur UK stamp duty or stamp duty reserve tax (currently 1.5% of the market value of the Shares converted) and fees of up to USD0.05 per ADR may be levied by Bank of New York Mellon upon conversion.


What action do I need to take?

If you wish to sell your holding before the proposed listing cancellation you must do so before 4.30pm on Friday 21 February 2020. The trade will be placed in accordance with our terms and conditions and subject to the standard Stockbrokers commission rates. To sell these shares please phone us on 0117 980 9800 or you can place a trade online. Please note that if the cash consideration of a sale does not exceed the commission payable then the sale will not be executed. Please note that although Hargreaves Lansdown will endeavor to sell your shares it may not be possible to sell all, or even any, of your shares if a market for the shares no longer exists.



If you wish to maintain your holding you need take no action. You should note that following the cancellation you may have difficulty selling this investment at a reasonable price and, in some circumstances, it may be impossible to sell it at any price.



Can I convert my Ordinary Shares to ADRs?

Shareholders have the option to convert their Ordinary Shares to ADRs (American Depository Receipts) that will continue to trade on NASDAQ in the US. They are currently trading at USD1.65



Each ADR represents 5 Summit Therapeutics plc Ordinary Shares, as such the conversion has to take place in multiples of 5 and it is not possible to receive a fraction of an ADR. Any holdings not in multiples of 5 will receive a fractional cash payment. Trades in ADRS will be settled in US Dollars in accordance with our Overseas Stockbroking terms and conditions.



If you wish to convert your Ordinary Shares into ADRs you will need to give an instruction before our deadline of noon on Wednesday 19 February 2020.



There is no conversion fee up until the delisting of the Shares from AIM. After close of business on 21 February 2020, conversion into ADRs may incur UK stamp duty or stamp duty reserve tax (currently 1.5% of the market value of the Shares converted) and fees of up to USD0.05 per ADR may be levied by Bank of New York Mellon upon conversion.



You can give an instruction to convert your Shares online by clicking on your Fund & Share Account in the ‘My Accounts’ section of our website. Please select the dark blue Corporate Actions Icon alongside Summit Therapeutics plc Shares and follow the instructions provided.



Please note, under HMRC rules the ADRs and Ordinary Shares will be unable to be held within a Stocks & Shares ISA as the underlying holding will not be listed on a recognised stock exchange. As a result any holding of Summit Therapeutics plc ADRs within a Stocks & Shares ISA will need to be removed within 30 days of the conversion.

[chrisatrdg] 10/2/2020 15:14

Tweet today re BARDA investment - all good exposure:

$SUMM Summit Therapeutics pleased with new BARDA partnership investment via @proactive_UK@Summitplc #SUMM

[chrisatrdg] 10/2/2020 10:23

I tweeted the following this morning:

'This has got to be one of the best Glyn Edward chats that I have ever heard and with the backing of a multibillionaire Mr Duggan & now moving fully onto the NASDAQ (SMMT) at current share price it has got to be one of the best bets for an investment in Biotech.'

[sikhthetech] 06/2/2020 13:12

1gw

"they would tap the US equity markets for more funds through a placing"

They already have warrants from the recent placing, why would they then tap the US equity market?

I don't think it's a coincidence that Mr Duggan's holding's is near 75% mark.




"In addition, a total of 26,306,765 warrants ("Investor Warrants") are proposed to be granted to the participants in the Subscription and the Placing, providing for the right to subscribe for an aggregate of 26,306,765 ordinary shares at a premium of 10 per cent. to the Offer Price. "

"If approved and completed, the Company expects that the
Fundraising will extend this runway by approximately 12 months to 31
January 2021. "

[chrisatrdg] 06/2/2020 13:09

Great RNS today on the day that I have finally sent my last share certificate to Interactive Investors for registration to enable me to convert them into ADD's next week.Well done Summit for achieving its milestone.

With regards going 'private' I am not sure Summit staff with options would be happy so not good for morale etc etc.

Edit: Pre market at $1.71 with a high of $1.81 looks going up finally.If I had the funds I would be Buying today AIM before the ADD's conversion.

[1gw] 06/2/2020 12:36

If they see signs of success I would have thought it more likely that they would tap the US equity markets for more funds through a placing, which would dilute the control of the existing major shareholders. They will in any case be subject to SEC rules won't they?

[sikhthetech] 06/2/2020 12:10

"Once the transfer out the way there won’t be much if anything holding the Nasdaq SMMT back!!"


except the directors holdings...

If they see signs of success I think they will take it private at around current share price ..

[kirk 6] 06/2/2020 12:10

Summit Therapeutics plc Summit Therapeutics To Receive $1.0 Million Milestone Payment From Eurofarma

[kirk 6] 06/2/2020 12:04

The only reason why there is a substantial disconnect from the Nasdaq line to the U.K. line is forced sellers before feb deadline date. Once the transfer out the way there won't be much if anything holding the Nasdaq SMMT back!!

[1gw] 06/2/2020 10:26

Just spoke to HL, who say they are planning to get a communication out early next week with details of what option is available to convert UK to US.

[1gw] 06/2/2020 08:09

So having bought into the UK and Nasdaq versions at about the same time, and actually having paid slightly more for the Nasdaq one, my portfolio is now showing +5% on the Nasdaq holding and -10% on the UK holding.

Where are the arb players?

[chrisatrdg] 06/2/2020 07:35

At last my certificate is on its way special delivery by Barclays currently tracking
their progress should receive before lunch.

On a more serious note current price on NASDAQ is $1.6984 looking good for this months conversion from Ord. Shares (AIM) into ADD's (NASDAQ).

Looking forward to next Mondays US conference call.

[freedosh] 05/2/2020 20:36

Or selling on AIM to buy back on Nasdaq - not a good deal but the easiest route. 🙁

[waterloo01] 05/2/2020 20:11

Maybe the virus scare is prompting interest in antibiotics?

[1gw] 05/2/2020 20:11

$1.72/(5*1.30) = 26.5p

Zacks have a buy on it apparently but I'd be surprised if that's enough to move it 10%. They only have a $1.75 target on it anyway, so it looks like we've already hit that.

[kirk 6] 05/2/2020 20:06

What's 1.72 equivalent is it 26p ?

[1gw] 05/2/2020 20:05

Very nice. But what's driving it, apart from a bit of volume? And will it be enough to move the bid price here tomorrow?

[waterloo01] 05/2/2020 20:02

Nice to see a bit of positive movement on Nasdaq

[someuwin] 05/2/2020 18:34

Summit Therapeutics @Summitplc

Our CEO, Glyn Edwards, chats with @JimGreenwood of @IAmBiotech
about all things #antibiotics, #antibioticresistance, #cdiff and #gonorrhoea